109
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients

, , , , , , & show all
Pages 1857-1865 | Published online: 04 Aug 2016

References

  • Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2016 [Updated 2016]. Available from: www.goldcopd.orgAccessed April 15, 2016
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
  • KesslerRStahlEVogelmeierCPatient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyChest2006130113314216840393
  • SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
  • PiquetJChavaillonJMDavidPMartinFBlanchonFRocheNHigh-risk patients following hospitalisation for an acute exacerbation of COPDEur Respir J201342494695523349446
  • SinganayagamASchembriSChalmersJDPredictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary diseaseAnn Am Thorac Soc2013102818923607835
  • GunenHHacievliyagilSSKosarFFactors affecting survival of hospitalised patients with COPDEur Respir J200526223424116055870
  • Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • AlmagroPCabreraFJDiezJWorking Group on COPD, Spanish Society of Internal MedicineComorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) studyChest201214251126113323303399
  • AlmagroPSalvadoMGarcia-VidalCRecent improvement in long-term survival after a COPD hospitalisationThorax201065429830220388752
  • ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • WangQBourbeauJOutcomes and health-related quality of life following hospitalization for an acute exacerbation of COPDRespirology200510333434015955146
  • MiravitllesMCalleMAlvarez-GutierrezFGobarttELopezFMartinAExacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary diseaseQual Life Res200615347148016547786
  • PouwEMTen VeldeGPCroonenBHKesterADScholsAMWoutersEFEarly non-elective readmission for chronic obstructive pulmonary disease is associated with weight lossClin Nutr2000192959910867726
  • Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 Suppl 2398s401s10843984
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • MatamisDTsagouriasMPapathanasiouATargeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of lifeJ Crit Care2014292315.e7e1424369757
  • LeeJHChangJHLung function in patients with chronic airflow obstruction due to tuberculous destroyed lungRespir Med200397111237124214635980
  • TalebMKhuderSTinkelJKhouriSJThe diagnostic accuracy of Doppler echocardiography in assessment of pulmonary artery systolic pressure: a meta-analysisEchocardiography201330325826523227919
  • BahadoriKFitzGeraldJMRisk factors of hospitalization and readmission of patients with COPD exacerbation – systematic reviewInt J Chron Obstruct Pulmon Dis20072324125118229562
  • JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
  • BeehKMGlaabTStowasserSCharacterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialRespir Res20131411624168767
  • LauACYamLYPoonEHospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary diseaseRespir Med2001951187688411716201
  • GadouryMASchwartzmanKRouleauMSelf-management reduces both short- and long-term hospitalisation in COPDEur Respir J200526585385716264046
  • MiravitllesMGuerreroTMayordomoCSanchez-AgudoLNicolauFSeguJLFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study GroupRespiration200067549550111070451
  • TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • HardinMSilvermanEKBarrRGThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
  • MenezesAMMontes de OcaMPerez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
  • MullerovaHShuklaAHawkinsAQuintJRisk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyBMJ Open2014412e006171
  • DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
  • CampoGPavasiniRMalaguMChronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical managementCardiovasc Drugs Ther201529214715725645653
  • YinLLensmarCIngelssonEBackMDifferential association of chronic obstructive pulmonary disease with myocardial infarction and ischemic stroke in a nation-wide cohortInt J Cardiol2014173360160324704409
  • KaradenizGPolatGSenolGBuyuksirinMC-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbationsInflammation201336494895323547018
  • ClarkTWMedinaMJBathamSCurranMDParmarSNicholsonKGC-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPDEur Respir J2015451768625186260
  • StolzDChrist-CrainMMorgenthalerNGCopeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPDChest200713141058106717426210
  • ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
  • CaoZOngKCEngPTanWCNgTPFrequent hospital readmissions for acute exacerbation of COPD and their associated factorsRespirology200611218819516548905
  • GonzalezCServeraEFerrisGBlascoMLMarinJFactores predictivos de reingreso hospitalario en la agudización de la EPOC moderada-grave [Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease]Arch Bronconeumol2004401150250715530342
  • LeuppiJDSchuetzPBingisserRShort-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJAMA2013309212223223123695200
  • Ministry of Health and Welfare Republic of KoreaOECD Health Data 2013SejongMinistry of Health and Welfare2013